pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 19·1 min read
save

Trump administration expected to nominate White House policy aide Heidi Overton as FDA commissioner

Aug 19, 2026·read at STAT ↗RegulatoryNeutral

President Donald Trump is expected to put forward White House deputy director of domestic policy Heidi Overton as the next commissioner of the U.S. Food and Drug Administration, according to STAT.

Overton, who has served in the White House focusing on domestic policy issues, would take over the agency that oversees drug approvals, safety and public health, though no official announcement has been made yet.

In the same briefing, Novo Nordisk disclosed that it is testing lower doses of its oral Wegovy formulation to determine the minimum amount needed for effective weight loss.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more”

read at STAT ↗
708 words · retrieved Aug 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.5NOVO2Novo Nordisk Inc2ASTRAZENECABRISTOL
drugs
Ozempic2Wegovy2Wegovy Pill2
topics
mRNA Therapeutic5Oncology4Vaccine3Obesity2ApprovalMelanomaSmall MoleculeVaccines

related stories

  • Aug 26Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealedBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 3h agoFoghorn cuts 40% of workforceBioSpace
  • Jun 1CDC says containing the spread of Ebola is top prioritySTAT
  • Aug 28STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and moreSTAT